Rika Yuliwulandari

Surabaya, JI 60294, Indonesia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.

Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.

Journal: PloS one

Published: April 15, 2026

Natural disaster and medication preparedness among elderly: a scoping review.

Natural disaster and medication preparedness among elderly: a scoping review.

Journal: F1000Research

Published: May 28, 2025

Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.

Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.

Journal: PloS one

Published: January 24, 2025

Frequencies of HLA-B alleles in Indonesian Malay Ethnic.

Frequencies of HLA-B alleles in Indonesian Malay Ethnic.

Journal: Heliyon

Published: October 17, 2023

Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis.

Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: September 06, 2022

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.

Journal: PloS one

Published: December 27, 2021

Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis.

Development of population pharmacokinetics model of isoniazid in Indonesian patients with tuberculosis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: December 02, 2021

Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in Indonesia.

Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in Indonesia.

Journal: Pharmacogenomics

Published: January 05, 2021

Association of disease severity with toll-like receptor polymorphisms in multidrug-resistant tuberculosis patients.

Association of disease severity with toll-like receptor polymorphisms in multidrug-resistant tuberculosis patients.

Journal: International journal of mycobacteriology

Published: December 16, 2020

Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm).

Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm).

Journal: Human genome variation

Published: July 24, 2020

NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population.

NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population.

Journal: Pharmacogenomics

Published: November 09, 2019

Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.

Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model.

Journal: The pharmacogenomics journal

Published: May 08, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026